Nosantine racemate 是 Nosantine 的外消旋体。Nosantine是一种 IL-2 诱导剂或诱导 IL-2 的增强剂。 CA-074 methyl ester产品描述:CA-074 methyl ester is a specific inhibitor of Cathepsin B, which has potent bioactivities such as neuroprotective, anti-cancer, and anti-inflamatory effects.In Vitro: CA-074Me (5 μM and 50 μM) inhibits RANKL-induced osteoclastogenesis in BMM cells derived from C57BL/6J and NOD/ShiLtJ mice. CA-074Me exerts its anti-osteoclastogenic effect within 24 hours post-RANKL stimulation in vitro. CA-074Me does not exert its anti-osteoclastogenic effect via the MAPK-ERK signaling cascade. CA-074Me inhibits c-FOS upregulation and subsequent NFATc1 autoamplification following RANKL stimulation.[2]. CA-074Me reduces apoptosis induced by CVB1[3]. In Vivo: Hippocampal CA1 neuronal programmed necrosis induced by global cerebral I/R injury is prevented by CA074-me (1 μg, 10 μg) both pre-treatment and post-treatment. The rupture of lysosomal membrane and the leakage of cathepsin-B, and this is strongly inhibited by CA074-me pre-treatment. The 公司介绍:MedChemExpress(MCE)专注于各种抑制剂、激动剂、API及化合物库,总部位于美国新泽西,分别在瑞典和上海设有欧洲区子公司和亚洲区总代理,营销网点遍及全球20多个国家地区。MCE经过多年努力已成为全球生物活性小分子领域的一流供应商, 产品涵盖癌症、神经科学、抗感染、表观遗传学等20个热门研究领域,PI3K、MAPK等近千个细分靶点,超过4000个活性小分子化合物现货,以及GPCR、API、离子通道等超过20种不同类型的化合物库,同时提供从毫克到千克的专业定制合成服务。 MCE 对每批产品都进行严格的LCMS和NMR检验,其产品已被全球近万名客户广泛使用并发表大量文章、专利; MCE 定期增加各领域热门抑制剂、激动剂,不断扩增已有化合物库,以满足最新的科研需求; 数千种产品在上海有充足备货,24-48小时内送达客户; 大量产品提供免费试用装;已为全球多个知名企业、院校构建各种定制型化合物库。 产品链接:www.medchemexpress.cn/CA-074-methyl-ester.html ![]() MWt:278.3501 Formula:C14H22N4O2 SMILES:O=C1N=CNC2=C1N=CN2C(C(O)C)CCCCCC Pathway:Immunology/Inflammation; Mechanisms:Interleukin Related; Research Area:Inflammation/Immunology 电话: 021-58955995 网址: www.MedChemExpress.cn 地址: 上海市浦东新区蔡伦路720号2号楼3层 |
Nosantine (racemate)前沿研究进展
发布日期:2017-11-13 浏览次数:2
核心提示:Nosantine racemate 是 Nosantine 的外消旋体。Nosantine是一种 bIL-2/b 诱导剂或诱导 bIL-2/b 的增强剂。BRa href=https://www.
- 下一篇:QF0301B前沿研究进展
- 上一篇:LM-1484前沿研究进展
行业动态
更多...
- QF0301B前沿研究进展 11-13
- Nosantine (racemate)前沿 11-13
- LM-1484前沿研究进展 11-13
- Iganidipine前沿研究进展 11-13
- Nitroxazepine前沿研究进 11-13
- Deriglidole前沿研究进展 11-13
- Sch-42495 (racemate)前沿 11-13
- Utibapril前沿研究进展 11-13
- YM-58790前沿研究进展 11-13
- RG-12525前沿研究进展 11-13